US2021269817A1PendingUtilityA1
Inhibition of bolting and flowering of a beta vulgaris plant
Est. expiryOct 30, 2035(~9.3 yrs left)· nominal 20-yr term from priority
C07K 14/415C12N 15/8218C12N 15/8267A01H 1/1215C12N 15/827C12N 15/8222C12N 15/8265A01H 6/024A01H 5/04
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides means for inhibiting the bolting and flowering of a Beta vulgaris plant, including an isolated nucleic acid, which can be used to produce a transgenic Beta vulgaris plant, where bolting and flowering is inhibited after vernalization. Furthermore, the invention discloses vectors, transgenic and non-transgenic, non-bolting plants and parts thereof, and methods for producing such plants.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . A method for producing a Beta vulgaris plant, where the bolting and flowering is inhibited after vernalization, comprising the following steps:
(I) mutagenizing one or more parts of a Beta vulgaris plant and subsequently regenerating one or more Beta vulgaris plants from one or more parts to yield a regenerated plant, or mutagenizing on or more Beta vulgaris plants to yield a mutagenized plant; (II) identifying a regenerated or mutagenized plant of (I) that exhibits one or more mutations in an endogenous DNA sequence; (III) generating a Beta vulgaris plant in which the one or more mutations in the endogenous DNA sequence is homozygous;
wherein the endogenous DNA sequence has a nucleic acid sequence identical to a sequence that
A) exhibits a sequence comprising the coding sequence of SEQ ID NO: 4,
B) comprises a nucleotide sequence exhibiting at least 98% sequence identity to the coding sequence of SEQ ID NO: 4;
C) is complementary to SEQ ID NO: 4; or
D) encodes a protein comprising an amino acid sequence exhibiting at least 98% sequence identity to SEQ ID NO: 6.
17 . A Beta vulgaris plant, produced by the method of claim 16 .
18 . A Beta vulgaris plant, wherein bolting and flowering is inhibited after vernalization, wherein the plant comprises one or more mutations in an endogenous DNA sequence comprising a nucleic acid sequence identical to a sequence that
a) comprises a sequence comprising the coding sequence of SEQ ID NO: 4, b) comprises a nucleotide sequence exhibiting at least 98% sequence identity to the coding sequence of SEQ ID NO: 4, c) is complementary to SEQ ID NO: 4, or d) encodes a protein comprising the amino acid sequence of SED ID NO: 6 or encodes a protein comprising an amino acid sequence exhibiting at least 98% sequence identity to SEQ ID NO: 6,
wherein the one or more mutations cause a reduction of the activity or stability of the protein or polypeptide encoded by the endogenous DNA sequence compared to a non-mutagenized wild type plant.Join the waitlist — get patent alerts
Track US2021269817A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.